Are Drugs Approved Too Quickly?
Nordenberg examines whether the FDA is rushing to approve drugs that may ultimately prove dangerous to patients. In an interview, Janet Woodcock of the FDA discusses the agency's approach to evaluating risks.
Gespeichert in:
Veröffentlicht in: | Consumers' research magazine 1999-10, Vol.82 (10), p.21 |
---|---|
1. Verfasser: | |
Format: | Magazinearticle |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Nordenberg examines whether the FDA is rushing to approve drugs that may ultimately prove dangerous to patients. In an interview, Janet Woodcock of the FDA discusses the agency's approach to evaluating risks. |
---|---|
ISSN: | 0095-2222 |